Illness	Number of cases
Malignant neoplasm of prostate (C61)	216
Hyperplasia of prostate (N40)	157
Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9)	89
Calculus of kidney and ureter - Calculus of kidney (N20.0)	75
Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5)	61
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	53
Calculus of kidney and ureter - Calculus of ureter (N20.1)	53
Malignant neoplasm of kidney except renal pelvis (C64)	31
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	26
Urethral stricture (N35.9)	24

Top 10 treatments

Treatment	Number
(1-999.40)	753
Examination of the urethra and the urinary bladder by endoscopy (1-661)	742
Injection or administration of medicines into the urinary bladder (8-132.3)	476
Operation using a surgical robot (5-987.0)	274
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	170
Surgical removal of the prostate, of the seminal vesicle and the associated lymph nodes (5-604.52)	156
Examination of the ureter by endoscopy (1-665)	149
Insertion, exchange or removal of a ureteral stent (8-137.10)	142
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41)	128
Insertion, exchange or removal of a ureteral stent (8-137.00)	120

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Mixed main and occupancy ward

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ28

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
87	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
77	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
77	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Doctoral supervision